These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33189932)

  • 1. Tau-related white-matter alterations along spatially selective pathways.
    Wen Q; Risacher SL; Xie L; Li J; Harezlak J; Farlow MR; Unverzagt FW; Gao S; Apostolova LG; Saykin AJ; Wu YC
    Neuroimage; 2021 Feb; 226():117560. PubMed ID: 33189932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease.
    Tian J; Raghavan S; Reid RI; Przybelski SA; Lesnick TG; Gebre RK; Graff-Radford J; Schwarz CG; Lowe VJ; Kantarci K; Knopman DS; Petersen RC; Jack CR; Vemuri P
    Neurology; 2023 May; 100(22):e2269-e2278. PubMed ID: 37068958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixel-Based Analysis Reveals Tau-Related White Matter Changes in Early Stages of Alzheimer's Disease.
    Ahmadi K; Pereira JB; van Westen D; Pasternak O; Zhang F; Nilsson M; Stomrud E; Spotorno N; Hansson O
    J Neurosci; 2024 May; 44(18):. PubMed ID: 38565289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition.
    Raghavan S; Przybelski SA; Reid RI; Lesnick TG; Ramanan VK; Botha H; Matchett BJ; Murray ME; Reichard RR; Knopman DS; Graff-Radford J; Jones DT; Lowe VJ; Mielke MM; Machulda MM; Petersen RC; Kantarci K; Whitwell JL; Josephs KA; Jack CR; Vemuri P
    Acta Neuropathol Commun; 2022 Feb; 10(1):16. PubMed ID: 35123591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Alzheimer's Disease Pathology and Small Vessel Disease With Cerebral White Matter Degeneration: A Tract-Based MR Diffusion Imaging Study.
    Li K; Wang S; Luo X; Zeng Q; Liu X; Hong L; Li J; Hong H; Xu X; Zhang Y; Jiaerken Y; Zhang R; Xie L; Xu S; Zhang X; Chen Y; Liu Z; Zhang M; Huang P
    J Magn Reson Imaging; 2024 Jul; 60(1):268-278. PubMed ID: 37737474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
    Kim WH; Racine AM; Adluru N; Hwang SJ; Blennow K; Zetterberg H; Carlsson CM; Asthana S; Koscik RL; Johnson SC; Bendlin BB; Singh V
    Neuroimage Clin; 2019; 21():101586. PubMed ID: 30502079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment.
    Amlien IK; Fjell AM
    Neuroscience; 2014 Sep; 276():206-15. PubMed ID: 24583036
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Moscoso A; Silva-Rodríguez J; Aldrey JM; Cortés J; Pías-Peleteiro JM; Ruibal Á; Aguiar P;
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1242-1253. PubMed ID: 34581847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of deposition of tau and amyloid-β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer's disease spectrum patients.
    Shigemoto Y; Sone D; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Sato N; Matsuda H
    Brain Behav; 2018 Dec; 8(12):e01145. PubMed ID: 30358161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions.
    Strain JF; Smith RX; Beaumont H; Roe CM; Gordon BA; Mishra S; Adeyemo B; Christensen JJ; Su Y; Morris JC; Benzinger TLS; Ances BM
    Neurology; 2018 Jul; 91(4):e313-e318. PubMed ID: 29959265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.
    Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M
    J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
    Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
    Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurite orientation dispersion and density imaging reveals white matter and hippocampal microstructure changes produced by Interleukin-6 in the TgCRND8 mouse model of amyloidosis.
    Colon-Perez LM; Ibanez KR; Suarez M; Torroella K; Acuna K; Ofori E; Levites Y; Vaillancourt DE; Golde TE; Chakrabarty P; Febo M
    Neuroimage; 2019 Nov; 202():116138. PubMed ID: 31472250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal disruption in white matter underlying cortical sulcus tau pathology in chronic traumatic encephalopathy.
    Holleran L; Kim JH; Gangolli M; Stein T; Alvarez V; McKee A; Brody DL
    Acta Neuropathol; 2017 Mar; 133(3):367-380. PubMed ID: 28214960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.